Skip to content
Pfizer Inc. announced on Wednesday it completed its nearly $5.4 billion acquisition of Global Blood Therapeutics, Inc. (GBT), the pioneer in treatments for sickle […]
Pfizer completes $5.4 billion acquisition of Global Blood Therapeutics Read More »
Vir Biotechnology Inc. has won a multi-year agreement with the U.S. government to support pandemic preparedness for influenza and other infectious disease threats, the
Vir Biotechnology gets government funding to address flu and future pandemics Read More »
With the COVID-19 pandemic still going strong, we were struck by the monkeypox outbreak in May, even though a vaccine existed. “Why weren’t we
Monkeypox outbreak: Did we learn anything to help us tackle the next threat? Read More »
Policymakers and public health leaders have been playing a dangerous game when it comes to how they are preparing, or rather are not preparing,
Shionogi shows how a biotech firm can tackle AMR Read More »
“Cancer’s resistance to treatments is the biggest challenge faced today in oncology, and this resistance is the cause of death from the disease,” said
OncoXome is charging ahead with gene therapy to treat resistant cancers Read More »
A subvariant of Omicron by the name of BA.2.75.2 is the most recent strain of COVID-19 causing concern. This variant has already developed the
New Omicron subvariant could create challenges this fall Read More »
The Food and Drug Administration (FDA) on Thursday authorized a new medication intended to halt the progression of amyotrophic lateral sclerosis (ALS), also known
FDA approves new ALS drug funded partially by ‘Ice Bucket Challenge’ Read More »
In a monumental victory for the people in Oregon, biotech innovation, and the Biotechnology Innovation Organization (BIO), the Accelerated Approval pathway will be preserved
Oregon preserves Medicaid coverage for ‘Accelerated Approval’ drugs Read More »
An experimental Alzheimer’s drug developed by Biotechnology Innovation Organization’s (BIO) members Eisai Co Ltd and Biogen slowed the cognitive and functional decline in a
Eisai and Biogen’s Alzheimer’s drug slows cognitive decline, study shows Read More »
Almost 80% of patients hospitalized with COVID-19 from March 2020 to October 2020 received an antibiotic, even though less than 3% had any bacterial
Antibiotics misuse and overprescribing revisited ahead of expected fall COVID wave Read More »
